BlackRock's Profit Fell, Assets Hit Record $14 Trillion, in Fourth Quarter
wsj.com
Want to monitor GSK?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor GSKGSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines.